Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N ATKINSON

Showing results (181-190 of 262) with videos related to

Pageof 27
Sort By:
Bioorganic & Medicinal Chemistry Letters|June 24, 2000
4-[(8-Alkyl-8-azabicyclo[3.2.1]octyl-3-yl)-3-arylanilino]-N,N-diethylbenzamides: high affinity, selective ligands for the delta opioid receptor illustrate factors important to antagonist activityJ B Thomas, R N Atkinson, R B Rothman, et al.
Polar Biology|February 7, 2022
An on-ice aerial survey of the Kane Basin polar bear (<i>Ursus maritimus</i>) subpopulationØystein Wiig, Stephen N Atkinson, Erik W Born, et al.
Geburtshilfe Und Frauenheilkunde|April 1, 1995
[Prognostic differentiation of ovarian carcinomas by immunohistochemical analysis of estrogen receptor expression]D G Kieback, M F Press, S K McCamant, et al.
Cancer Research|May 6, 2004
Myristoylation of the fus1 protein is required for tumor suppression in human lung cancer cellsFutoshi Uno, Jiichiro Sasaki, Masahiko Nishizaki, et al.
Nature Communications|February 13, 2024
Polar bear energetic and behavioral strategies on land with implications for surviving the ice-free periodAnthony M Pagano, Karyn D Rode, Nicholas J Lunn, et al.
Gynecologic Oncology|May 11, 2005
Phase II trial of capecitabine in recurrent squamous cell carcinoma of the cervixAlfred D Jenkins, Lois M Ramondetta, Charlotte Sun, et al.
Anticancer Research|November 1, 1993
Prognostic significance of estrogen receptor expression in ovarian cancer. Immunoreactive Score (IRS) vs. Composition Adjusted Receptor Level (CARL)D G Kieback, M F Press, E N Atkinson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2001
A randomized clinical trial of 4-hydroxyphenylretinamide for high-grade squamous intraepithelial lesions of the cervixM Follen, E N Atkinson, D Schottenfeld, et al.
Journal of Medicinal Chemistry|November 13, 2007
Synthesis and nicotinic acetylcholine receptor binding properties of bridged and fused ring analogues of epibatidineF Ivy Carroll, T Philip Robinson, Lawrence E Brieaddy, et al.
Gynecologic Oncology|October 1, 1992
The effect of prolonged cisplatin-based chemotherapy on progression-free survival in patients with optimal epithelial ovarian cancer: "maintenance" therapy reconsideredD M Gershenson, M F Mitchell, N Atkinson, et al.
Pageof 27

Showing results (181-190 of 262) with videos related to

Sort By:
Pageof 27
Bioorganic & Medicinal Chemistry Letters|June 24, 2000
4-[(8-Alkyl-8-azabicyclo[3.2.1]octyl-3-yl)-3-arylanilino]-N,N-diethylbenzamides: high affinity, selective ligands for the delta opioid receptor illustrate factors important to antagonist activityJ B Thomas, R N Atkinson, R B Rothman, et al.
Polar Biology|February 7, 2022
An on-ice aerial survey of the Kane Basin polar bear (<i>Ursus maritimus</i>) subpopulationØystein Wiig, Stephen N Atkinson, Erik W Born, et al.
Geburtshilfe Und Frauenheilkunde|April 1, 1995
[Prognostic differentiation of ovarian carcinomas by immunohistochemical analysis of estrogen receptor expression]D G Kieback, M F Press, S K McCamant, et al.
Cancer Research|May 6, 2004
Myristoylation of the fus1 protein is required for tumor suppression in human lung cancer cellsFutoshi Uno, Jiichiro Sasaki, Masahiko Nishizaki, et al.
Nature Communications|February 13, 2024
Polar bear energetic and behavioral strategies on land with implications for surviving the ice-free periodAnthony M Pagano, Karyn D Rode, Nicholas J Lunn, et al.
Gynecologic Oncology|May 11, 2005
Phase II trial of capecitabine in recurrent squamous cell carcinoma of the cervixAlfred D Jenkins, Lois M Ramondetta, Charlotte Sun, et al.
Anticancer Research|November 1, 1993
Prognostic significance of estrogen receptor expression in ovarian cancer. Immunoreactive Score (IRS) vs. Composition Adjusted Receptor Level (CARL)D G Kieback, M F Press, E N Atkinson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2001
A randomized clinical trial of 4-hydroxyphenylretinamide for high-grade squamous intraepithelial lesions of the cervixM Follen, E N Atkinson, D Schottenfeld, et al.
Journal of Medicinal Chemistry|November 13, 2007
Synthesis and nicotinic acetylcholine receptor binding properties of bridged and fused ring analogues of epibatidineF Ivy Carroll, T Philip Robinson, Lawrence E Brieaddy, et al.
Gynecologic Oncology|October 1, 1992
The effect of prolonged cisplatin-based chemotherapy on progression-free survival in patients with optimal epithelial ovarian cancer: "maintenance" therapy reconsideredD M Gershenson, M F Mitchell, N Atkinson, et al.
Pageof 27